Omnicare (FRA:OMN) Loans Receivable : €0 Mil (As of Jun. 2015)

View and export this data going back to . Start your Free Trial

What is Omnicare Loans Receivable?

Omnicare's Loans Receivable for the quarter that ended in Jun. 2015 was €0 Mil.

Omnicare Loans Receivable Historical Data

The historical data trend for Omnicare's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicare Loans Receivable Chart

Omnicare Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Loans Receivable

Get a 7-Day Free Trial

Omnicare Quarterly Data
	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15
Loans Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Omnicare Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Omnicare Loans Receivable Related Terms

Thank you for viewing the detailed overview of Omnicare's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Omnicare (FRA:OMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicare Inc (FRA:OMN) » Definitions » Loans Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.omnicare.com

Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.